PCN8 Axitinib (AXI) and Best Supportive Care (BSC) in the Treatment of Sunitinib-Refractory Patients With Metastatic Renal Cell Carcinoma (mRCC)- Results of a Simulated Treatment Comparison (STC) Analyses
Abstract
Authors
I. Proskorovsky A. Benedict J.M.G. Larkin R. Sandin C. Chen